BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Harder J, Müller MJ, Fuchs M, Gumpp V, Schmitt-Graeff A, Fischer R, Frank M, Opitz O, Hasskarl J. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer. World J Gastroenterol 2013; 19(48): 9334-9342 [PMID: 24409060 DOI: 10.3748/wjg.v19.i48.9334]
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9334.htm
Number Citing Articles
1
Christophe Desterke, Chuhan Chung, David Pan, Michael Trauner, Didier Samuel, Daniel Azoulay, Cyrille Feray. Early Deregulation of Cholangiocyte NR0B2 During Primary Sclerosing CholangitisGastro Hep Advances 2023; 2(1): 49 doi: 10.1016/j.gastha.2022.07.023
2
Lifeng Huang, Jie Cai, Han Guo, Jinyang Gu, Ying Tong, Bijun Qiu, Chenchen Wang, Meng Li, Lei Xia, Jianjun Zhang, Hailong Wu, Xiaoni Kong, Qiang Xia. ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic CholangiocarcinomaHepatology 2019; 69(5): 1995 doi: 10.1002/hep.30404
3
Marlena Beyreis, Martin Gaisberger, Martin Jakab, Daniel Neureiter, Katharina Helm, Markus Ritter, Tobias Kiesslich, Christian Mayr. The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell CharacteristicsCancers 2019; 11(3): 276 doi: 10.3390/cancers11030276
4
Ali Belkouz, Tim A. Labeur, Joeri Dierks, Frederike Dijk, Martijn G.H. van Oijen, Joanne Verheij, Thomas M. van Gulik, Marc J. van de Vijver, Hanneke Wilmink, Cornelis J.A. Punt, Heinz-Josef Klümpen. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology 2019; 141: 82 doi: 10.1016/j.critrevonc.2019.06.001